Skip to main content Accessibility help
×
Home
Hostname: page-component-559fc8cf4f-28jzs Total loading time: 0.406 Render date: 2021-02-25T17:39:52.974Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": false, "newCiteModal": false, "newCitedByModal": true }

Dementia clinical trial implications of mild behavioral impairment

Published online by Cambridge University Press:  16 February 2018

Moyra E. Mortby
Affiliation:
Centre for Research on Ageing, Health and Wellbeing, Research School of Population Health, The Australian National University, Canberra, Australia NHMRC National Institute for Dementia Research, Canberra, Australia
Sandra E. Black
Affiliation:
Department of Medicine (Neurology), Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook HSC, University of Toronto, Toronto, Canada
Serge Gauthier
Affiliation:
McGill Center for Studies in Aging, Douglas Mental Health Research Institute, Montreal, Canada
David Miller
Affiliation:
Bracket Global, Wayne, Pennsylvania, USA
Anton Porsteinsson
Affiliation:
Alzheimer's Disease Care, Research and Education Program (AD-CARE), University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
Eric E. Smith
Affiliation:
Department of Clinical Neurosciences, Ron and Rene Ward Centre for Healthy Brain Aging, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada
Zahinoor Ismail
Affiliation:
Department of Clinical Neurosciences, Ron and Rene Ward Centre for Healthy Brain Aging, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada Department of Psychiatry, Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, Canada
Corresponding
E-mail address:

Extract

The World Alzheimer Report 2016 estimated that 47 million people are living with dementia worldwide (Alzheimer's Disease International, 2016). In the inaugural World Health Organization Ministerial Conference on Global Action against Dementia, six of the top ten research priorities were focused on prevention, identification, and reduction of dementia risk, and on delivery and quality of care for people with dementia and their carers (Shah et al., 2016). While the Lancet Neurology Commission has suggested that even minor advances to delay progression or ameliorate symptoms might have substantial financial and societal benefits (Winblad et al., 2016), advances have been slow.

Type
Commentary
Copyright
Copyright © International Psychogeriatric Association 2018 

Access options

Get access to the full version of this content by using one of the access options below.

References

Almeida, O., Hankey, G., Yeap, B., Golledge, J. and Flicker, L. (2017). Depression as a modifiable factor to decrease the risk of dementia. Translational Psychiatry, 7, e1117.CrossRefGoogle Scholar
Babulal, G. M. et al. (2016). Mood changes in cognitively normal older adults are linked to Alzheimer disease biomarker levels. The American Journal of Geriatric Psychiatry, 24, 10951104.CrossRefGoogle ScholarPubMed
Banzi, R., Camaioni, P., Tettamanti, M. and Lucca, U. (2016). Older patients are still under-represented in clinical trials of Alzheimer's disease. Alzheimer's Research & Therapy, 8, 32.CrossRefGoogle ScholarPubMed
Del Campo, N. et al. (2016). Relationship of regional brain β-amyloid to gait speed. Neurology, 86, 3643.CrossRefGoogle ScholarPubMed
Desmarais, P., Lanctôt, K. L., Masellis, M., Black, S. E. and Herrmann, N. (2017). Social inappropriateness in neurodegenerative disorders. International Psychogeriatrics, 111. doi:10.1017/S1041610217001260 Google ScholarPubMed
Donovan, N. J. et al. (2014). Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum. The American Journal of Geriatric Psychiatry, 22, 11681179.CrossRefGoogle ScholarPubMed
Fargo, K. N., Carrillo, M. C., Weiner, M. W., Potter, W. Z. and Khachaturian, Z. (2016). The crisis in recruitment for clinical trials in Alzheimer's and dementia: an action plan for solutions. Alzheimer's & Dementia, 12, 11131115.CrossRefGoogle ScholarPubMed
Fernández-Matarrubia, M., Matias-Guiu, J., Moreno-Ramos, T. and Matias-Guiu, J. (2015). Biomarkers: a new approach to behavioural variant frontotemporal dementia. Neurología (English Edition), 30, 5061.CrossRefGoogle ScholarPubMed
Fischer, C. E. and Agüera-Ortiz, L. (2017). Psychosis and dementia: risk factor, prodrome, or cause? International Psychogeriatrics, 111. doi:10.1017/S1041610217000874 Google ScholarPubMed
Gauthier, S. et al. (2016). Why has therapy development for dementia failed in the last two decades? Alzheimer's & Dementia, 12, 6064.CrossRefGoogle ScholarPubMed
Graham, W. V., Bonito-Oliva, A. and Sakmar, T. P. (2017). Update on Alzheimer's disease therapy and prevention strategies. Annual Review of Medicine, 68, 413430.Google ScholarPubMed
Hellmuth, J. et al. (2012). Multicenter validation of a bedside antisaccade task as a measure of executive function. Neurology, 78, 18241831.CrossRefGoogle ScholarPubMed
Alzheimer's Disease International (2016). World Alzheimer's report.Google Scholar
Ismail, Z. and Mortby, M. E. (2017). Cognitive and neuropsychiatric screening tests in older adults. In Chiu, H. and Shulman, K. (eds.), Mental Health and Illness of the Elderly. New Delhi: Springer.Google Scholar
Ismail, Z. et al. (2016). Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimer's & Dementia, 12, 195202.CrossRefGoogle ScholarPubMed
Ismail, Z. et al. (2017a). The mild behavioral impairment checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations. Journal of Alzheimer's Disease, 56, 929938.CrossRefGoogle ScholarPubMed
Ismail, Z. et al. (2017b). Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria. International Psychogeriatrics, 112. doi:10.1017/S1041610217001880 Google ScholarPubMed
Jalal, H., Ganesh, A., Lau, R., Lysack, J. and Ismail, Z. (2014). Cholinesterase-inhibitor associated mania: a case report and literature review. The Canadian Journal of Neurological Sciences, 41, 278280.CrossRefGoogle ScholarPubMed
Kwan-Chun Ting, W., Fischer, C. E., Millikin, C. P., Ismail, Z., Chow, T. W. and Schweizer, T. A. (2015). Grey matter atrophy in mild cognitive impairment/early Alzheimer disease associated with delusions: a voxel-based morphometry study. Current Alzheimer Research, 12, 165172.CrossRefGoogle ScholarPubMed
Ladas, A., Frantzidis, C., Bamidis, P. and Vivas, A. B. (2014). Eye blink rate as a biological marker of mild cognitive impairment. International Journal of Psychophysiology, 93, 1216.CrossRefGoogle ScholarPubMed
Lanctôt, K. L. et al. (2016). Apathy associated with neurocognitive disorders: recent progress and future directions. Alzheimer's & Dementia.Google Scholar
Lin, F. R., Metter, E. J., O'Brien, R. J., Resnick, S. M., Zonderman, A. B. and Ferrucci, L. (2011). Hearing loss and incident dementia. Archives of Neurology, 68, 214220.CrossRefGoogle ScholarPubMed
Mortby, M. E. and Anstey, K. J. (2015). Mental health and aging. In Pachana, A. N. (ed.), Encyclopedia of Geropsychology (pp. 16). Singapore: Springer Singapore.Google Scholar
Nagata, T., Kobayashi, N., Shinagawa, S., Yamada, H., Kondo, K. and Nakayama, K. (2014). Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease. Journal of Neural Transmission, 121, 433441.CrossRefGoogle ScholarPubMed
Ng, K. et al. (2017). Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer's disease. Neurology, 88, 18141821.CrossRefGoogle Scholar
Peters, K. et al. (2006). Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics. Neurology, 66, 523528.CrossRefGoogle ScholarPubMed
Shah, H. et al. (2016). Research priorities to reduce the global burden of dementia by 2025. The Lancet Neurology, 15, 12851294.CrossRefGoogle ScholarPubMed
Sheikh, F. et al. (2017). Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden. International Psychogeriatrics. doi:10.1017/S104161021700151X Google ScholarPubMed
Sherman, C., Liu, C. S., Herrmann, N. and Lanctôt, K. L. (2017). Prevalence, neurobiology, and treatments for apathy in prodromal dementia. International Psychogeriatrics, 18. doi:10.1017/S1041610217000527 Google ScholarPubMed
Singh-Manoux, A. et al. (2017). Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study. JAMA Psychiatry, 74, 712718. doi:10.1001/jamapsychiatry.2017.0660 CrossRefGoogle ScholarPubMed
Stanciu, I., Larsson, M., Nordin, S., Adolfsson, R., Nilsson, L.-G. and Olofsson, J. K. (2014). Olfactory impairment and subjective olfactory complaints independently predict conversion to dementia: a longitudinal, population-based study. Journal of the International Neuropsychological Society, 20, 209217.CrossRefGoogle ScholarPubMed
Tapiainen, V., Hartikainen, S., Taipale, H., Tiihonen, J. and Tolppanen, A.-M. (2017). Hospital-treated mental and behavioral disorders and risk of Alzheimer's disease: a nationwide nested case-control study. European Psychiatry, 43, 9298.CrossRefGoogle ScholarPubMed
Ting, C. et al. (2010). Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life. PLoS One, 5, e10151.CrossRefGoogle ScholarPubMed
Winblad, B. et al. (2016). Defeating Alzheimer's disease and other dementias: a priority for European science and society. The Lancet Neurology, 15, 455.CrossRefGoogle ScholarPubMed

Full text views

Full text views reflects PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.

Total number of HTML views: 58
Total number of PDF views: 351 *
View data table for this chart

* Views captured on Cambridge Core between 16th February 2018 - 25th February 2021. This data will be updated every 24 hours.

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Dementia clinical trial implications of mild behavioral impairment
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Dementia clinical trial implications of mild behavioral impairment
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Dementia clinical trial implications of mild behavioral impairment
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *